Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Signs on FPN, Expanding its Payor Network

NEW YORK (GenomeWeb News) – Response Genetics today announced it has signed a contract that provides the 4.1 million members in Fortified Provider Network access to Response Genetics' molecular predictive tests.

Based in Scottsdale, Ariz., FPN is a direct-contracted network of preferred providers. As a result of today's deal, FPN members associated with more than 200 health insurers, self-funded employers, and other payors of healthcare services will be able to access Response Genetics' tests at discounted rates.

The deal is the seventh such agreement reached by Los Angeles-based Response Genetics this year and brings the total number of patients with access to the company's tests to 97 million. Last week, it announced a contract with preferred provider organization Three Rivers Provider Network.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.